Role of the epithelial-mesenchymal transition in bladder cancer: from prognosis to therapeutic target
about
The role of microRNAs in bladder cancerTargeting Hsp90 in urothelial carcinomaUrothelial cells undergo epithelial-to-mesenchymal transition after exposure to muscle invasive bladder cancer exosomes.Zinc Finger E-Box Binding Protein 2 (ZEB2) Suppress Apoptosis of Vascular Endothelial Cells Induced by High Glucose Through Mitogen-Activated Protein Kinases (MAPK) Pathway ActivationRole of the microtubule-targeting drug vinflunine on cell-cell adhesions in bladder epithelial tumour cells.Modulation of E-cadherin expression promotes migration ability of esophageal cancer cells.Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERβ/CCL2/CCR2 EMT/MMP9 signalsCharacteristics of bladder transitional cell carcinoma with E-cadherin and N-cadherin double-negative expression.Circulating Biomarkers in Bladder Cancer.Noninvasive approaches for detecting and monitoring bladder cancer.PA-MSHA induces apoptosis and suppresses metastasis by tumor associated macrophages in bladder cancer cells.Research advances in HMGN5 and cancer.Knockdown of HMGN5 suppresses the viability and invasion of human urothelial bladder cancer 5637 cells in vitro and in vivo.Sonic hedgehog-Gli1 signals promote epithelial-mesenchymal transition in ovarian cancer by mediating PI3K/AKT pathway.NOV is upregulated and promotes migration and invasion in bladder cancer.Inhibition of mTOR pathway attenuates migration and invasion of gallbladder cancer via EMT inhibition.LncRNA UCA1 promotes the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway.T-cell immunoglobulin mucin-3 as a potential inducer of the epithelial-mesenchymal transition in hepatocellular carcinoma.Anticancer effect of S-allyl-L-cysteine via induction of apoptosis in human bladder cancer cells.Oxymatrine induces apoptosis and inhibits invasion in Gallbladder carcinoma via PTEN/PI3K/AKT pathway.Upregulation of Twist2 in Non-Muscle Invasive Urothelial Carcinoma of the Bladder Correlate with Response to Treatment and Progression.
P2860
Q26744149-D701F712-CA91-402F-BD6D-94310D9EDF2AQ27023406-2D252B32-15D5-47F1-9E13-DD2DAE3A92A6Q27309880-204E2E0E-F6AB-4B9D-BC65-ABDB6FBC3CAEQ33764076-9CF95685-AFAA-400A-A768-6A4346ACC7C1Q33938481-786826AF-FC36-4A44-A1C3-928C466255E5Q36602499-A6AB6C13-396A-42FE-99DE-36358567D392Q36946642-E46BA600-77A4-4F7A-8A07-00DBCDFF54CEQ37002826-F2AFAEBF-F74E-4B53-A132-8D15DAE2F564Q37530401-3975519F-F90D-4592-A409-29D9F9A6A21DQ38286089-A69F36CE-A2B3-40DA-B3D8-CAE2B9AC76EBQ38616860-C41D25BB-204F-4727-BA47-4BF9A179D0F3Q38678181-FDD7CFE3-FE81-460D-9A10-3FE00FEA93DDQ38896739-5FFFC3C1-2856-458E-8CB0-2A30EAF76583Q38937086-CD1FB4B7-6431-417A-BD36-55E2DC6DB546Q39005699-00B97F7E-2370-4ABF-A8A6-597430F448D2Q39016105-AF4D6B15-78D9-49E5-BCF6-C3A865DD6163Q43292714-7A00E86D-DCB3-4650-A85D-E37341A6DAC4Q46794523-86597F5B-D96A-4421-A100-1E284F2A50B1Q47163619-A05D3318-AEFA-41D3-9B7F-22835ED8EEEBQ49686713-C2AB38FD-B86C-4CAF-BBB7-9E65898B1C43Q55435482-BF4EEE4B-AC3B-48FC-A214-5895B25E3F82
P2860
Role of the epithelial-mesenchymal transition in bladder cancer: from prognosis to therapeutic target
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of the epithelial-mesench ...... rognosis to therapeutic target
@en
Role of the epithelial-mesench ...... ognosis to therapeutic target.
@nl
type
label
Role of the epithelial-mesench ...... rognosis to therapeutic target
@en
Role of the epithelial-mesench ...... ognosis to therapeutic target.
@nl
prefLabel
Role of the epithelial-mesench ...... rognosis to therapeutic target
@en
Role of the epithelial-mesench ...... ognosis to therapeutic target.
@nl
P2860
P1476
Role of the epithelial-mesench ...... rognosis to therapeutic target
@en
P2093
Wun-Jae Kim
P2860
P304
P356
10.4111/KJU.2013.54.10.645
P577
2013-10-15T00:00:00Z